AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid
Clinical trial NCT04468659 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04468659
- Sponsor
- Eisai Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-14
- Primary completion
- 2028-12-21
- Enrollment
- 1400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.